ResearcherUniversity of Southern CaliforniaActive in the last 2 years
Peter Kühn
Matched on ORCID iD 0000-0003-2629-4505; OpenAlex author ID A5000472988; NIH RePORTER profile ID 1861452. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 18
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers, 1 grant
Papers 5
- Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters. Co-author DOI 10.1016/j.canlet.2025.217546↗
- Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and prognostication of pancreatic cancer. Last author DOI 10.1038/s41698-025-01165-4↗
- Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. Co-author DOI 10.1038/s41698-024-00521-0↗
- Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the liquid biopsy. Co-author DOI 10.1038/s44276-024-00069-3↗
- A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-15-0979↗
Grants 1
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Simon K. Lo · 4 shared papers, 2024–2025 · strength 0.85
- Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
- Stephanie N. Shishido · 4 shared papers, 2024–2025 · strength 0.85
- Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
- Stephen Jacob Pandol · 4 shared papers, 2024–2025 · strength 0.85
- Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
- Nicholas N. Nissen · 2 shared papers, 2024–2025 · strength 0.43
- Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
- Paper Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. DOI 10.1038/s41698-024-00521-0↗
- Srinivas Gaddam · 2 shared papers, 2024–2025 · strength 0.43
- Paper Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and… DOI 10.1038/s41698-025-01165-4↗
- Paper Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. DOI 10.1038/s41698-024-00521-0↗
- Ruoxiang Wang · 2 shared papers, 2024–2025 · strength 0.42
- Paper Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered ad… DOI 10.1016/j.canlet.2025.217546↗
- Paper Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the… DOI 10.1038/s44276-024-00069-3↗
- Rabindra R. Watson · 1 shared paper, 2025 · strength 0.24
- Aurelia Lugea · 1 shared paper, 2025 · strength 0.23
- Richard T. Waldron · 1 shared paper, 2025 · strength 0.23
- Andrew Eugene Hendifar · 1 shared paper, 2024 · strength 0.19
- Arsen Osipov · 1 shared paper, 2024 · strength 0.19
- Andrew H. Ko · 1 shared paper, 2016 · strength 0.05
- Olga K. Mirzoeva · 1 shared paper, 2016 · strength 0.05
- Eric Andrew Collisson · 1 shared paper, 2016 · strength 0.05
- Wolfgang Michael Korn · 1 shared paper, 2016 · strength 0.05
- Alan Paul Venook · 1 shared paper, 2016 · strength 0.05
- Tanios Bekaii‐Saab · 1 shared paper, 2016 · strength 0.05
- Margaret A. Tempero · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.